Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
96M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
31.6M
-
Shares change
-
+3.64M
-
Total reported value, excl. options
-
$1.96B
-
Value change
-
+$230M
-
Put/Call ratio
-
0.74
-
Number of buys
-
89
-
Number of sells
-
-34
-
Price
-
$62.09
Significant Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2015
139 filings reported holding RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK as of Q1 2015.
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.6M shares
of 96M outstanding shares and own 32.89% of the company stock.
Largest 10 shareholders include FMR LLC (5.33M shares), Capital Research Global Investors (4.28M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (2.24M shares), TPG Group Holdings (SBS) Advisors, Inc. (1.6M shares), VANGUARD GROUP INC (1.6M shares), WELLINGTON MANAGEMENT GROUP LLP (1.57M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.25M shares), MILLENNIUM MANAGEMENT LLC (982K shares), ADAGE CAPITAL PARTNERS GP LLC (950K shares), and Visium Asset Management, LP (737K shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.